Moleculin Biotech Stock Forecast - Daily Balance Of Power

MBRX
 Stock
  

USD 1.76  0.01  0.56%   

Moleculin Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Moleculin Biotech historical stock prices and determine the direction of Moleculin Biotech CS's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading. Macroaxis recommends to always use this module together with analysis of Moleculin Biotech historical fundamentals such as revenue growth or operating cash flow patterns. Although Moleculin Biotech naive historical forecasting may sometimes provide an important future outlook for the firm we recommend to always cross-verify it against solid analysis of Moleculin Biotech CS systematic risk associated with finding meaningful patterns of Moleculin Biotech fundamentals over time.
Additionally, see Historical Fundamental Analysis of Moleculin Biotech to cross-verify your projections.
  
Moleculin Biotech Accumulated Other Comprehensive Income is fairly stable at the moment as compared to the past year. Moleculin Biotech reported Accumulated Other Comprehensive Income of 41,000 in 2021. Total Assets is likely to rise to about 90.7 M in 2022, whereas Accounts Payable is likely to drop slightly above 1.2 M in 2022.
Moleculin Biotech CS has current Daily Balance Of Power of (0.25).
Most investors in Moleculin Biotech cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Moleculin Biotech's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Moleculin Biotech's price structures and extracts relationships that further increase the generated results' accuracy.
Balance of Power indicator (or BOP) measures the strength of Moleculin Biotech CS market sensitivity to bulls and bears. It estimates the ability of Moleculin Biotech buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Moleculin Biotech Balance of Power indicator one can determine a trend of the price direction.
  Previous Daily Balance Of PowerDaily Balance Of PowerTrend
0.5556(0.25)
Check Moleculin Biotech VolatilityBacktest Moleculin BiotechInformation Ratio  

Moleculin Biotech Trading Date Momentum

On August 18 2022 Moleculin Biotech CS was traded for  1.76  at the closing time. The top price for the day was 1.79  and the lowest listed price was  1.75 . The trading volume for the day was 19.3 K. The trading history from August 18, 2022 did not cause price change. The trading delta at closing time against the current closing price is 0.57% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Moleculin Biotech to competition

Other Forecasting Options for Moleculin Biotech

For every potential investor in Moleculin, whether a beginner or expert, Moleculin Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Moleculin Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Moleculin. Basic forecasting techniques help filter out the noise by identifying Moleculin Biotech's price trends.

Moleculin Biotech Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Moleculin Biotech stock to make a market-neutral strategy. Peer analysis of Moleculin Biotech could also be used in its relative valuation, which is a method of valuing Moleculin Biotech by comparing valuation metrics with similar companies.
Walt DisneyAmn Healthcare ServicesTwist Bioscience CorpFreedom Holding CorpKEURIG DR PEPPERGx Nasdaq-100 CoveredFranklin Mutual EuropeanGARDNER DENVER INCUSA Value FactorBetapro Canadian GoldAramark Holdings CorpLong-Term Govt BondLIFE STORAGE INCMaiden Holdings NorthVistra Energy Corp
 Risk & Return  Correlation

Moleculin Biotech Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Moleculin Biotech's price movements, , a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Moleculin Biotech's current price.

Moleculin Biotech Market Strength Events

Market strength indicators help investors to evaluate how Moleculin Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Moleculin Biotech shares will generate the highest return on investment. By undertsting and applying Moleculin Biotech stock market strength indicators, traders can identify Moleculin Biotech CS entry and exit signals to maximize returns.

Moleculin Biotech Risk Indicators

The analysis of Moleculin Biotech's basic risk indicators is one of the essential steps in helping accuretelly forecast its future price. The process involves identifying the amount of risk involved in Moleculin Biotech's investment and either accepting that risk or mitigating it. Along with some funamental techniques of forecasting Moleculin Biotech stock price, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Moleculin Biotech without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Optimizer Now

   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Moleculin Biotech using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Historical Fundamental Analysis of Moleculin Biotech to cross-verify your projections. Note that the Moleculin Biotech information on this page should be used as a complementary analysis to other Moleculin Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Moleculin Stock analysis

When running Moleculin Biotech price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Is Moleculin Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moleculin Biotech. If investors know Moleculin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moleculin Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
50.6 M
Return On Assets
-0.19
Return On Equity
-0.28
The market value of Moleculin Biotech is measured differently than its book value, which is the value of Moleculin that is recorded on the company's balance sheet. Investors also form their own opinion of Moleculin Biotech's value that differs from its market value or its book value, called intrinsic value, which is Moleculin Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moleculin Biotech's market value can be influenced by many factors that don't directly affect Moleculin Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moleculin Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Moleculin Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moleculin Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.